Literature DB >> 26547088

Methods of defining hypertension in electronic medical records: validation against national survey data.

Mingkai Peng1, Guanmin Chen2, Gilaad G Kaplan3, Lisa M Lix4, Neil Drummond5, Kelsey Lucyk1, Stephanie Garies6, Mark Lowerison7, Samuel Weibe8, Hude Quan1.   

Abstract

BACKGROUND: Electronic medical records (EMR) can be a cost-effective source for hypertension surveillance. However, diagnosis of hypertension in EMR is commonly under-coded and warrants the needs to review blood pressure and antihypertensive drugs for hypertension case identification.
METHODS: We included all the patients actively registered in The Health Improvement Network (THIN) database, UK, on 31 December 2011. Three case definitions using diagnosis code, antihypertensive drug prescriptions and abnormal blood pressure, respectively, were used to identify hypertension patients. We compared the prevalence and treatment rate of hypertension in THIN with results from Health Survey for England (HSE) in 2011.
RESULTS: Compared with prevalence reported by HSE (29.7%), the use of diagnosis code alone (14.0%) underestimated hypertension prevalence. The use of any of the definitions (38.4%) or combination of antihypertensive drug prescriptions and abnormal blood pressure (38.4%) had higher prevalence than HSE. The use of diagnosis code or two abnormal blood pressure records with a 2-year period (31.1%) had similar prevalence and treatment rate of hypertension with HSE.
CONCLUSIONS: Different definitions should be used for different study purposes. The definition of 'diagnosis code or two abnormal blood pressure records with a 2-year period' could be used for hypertension surveillance in THIN.
© The Author 2015. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antihypertensive drug; blood pressure; diagnosis code; electronic medical records; hypertension

Mesh:

Substances:

Year:  2015        PMID: 26547088      PMCID: PMC5072168          DOI: 10.1093/pubmed/fdv155

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  18 in total

1.  Read Codes Version 3: a user led terminology.

Authors:  M O'Neil; C Payne; J Read
Journal:  Methods Inf Med       Date:  1995-03       Impact factor: 2.176

2.  Validating the 8 CPCSSN case definitions for chronic disease surveillance in a primary care database of electronic health records.

Authors:  Tyler Williamson; Michael E Green; Richard Birtwhistle; Shahriar Khan; Stephanie Garies; Sabrina T Wong; Nandini Natarajan; Donna Manca; Neil Drummond
Journal:  Ann Fam Med       Date:  2014-07       Impact factor: 5.166

3.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

4.  Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates.

Authors:  Betina T Blak; Mary Thompson; Hassy Dattani; Alison Bourke
Journal:  Inform Prim Care       Date:  2011

5.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

6.  Validation of a case definition to define hypertension using administrative data.

Authors:  Hude Quan; Nadia Khan; Brenda R Hemmelgarn; Karen Tu; Guanmin Chen; Norm Campbell; Michael D Hill; William A Ghali; Finlay A McAlister
Journal:  Hypertension       Date:  2009-10-26       Impact factor: 10.190

7.  Hypertension guideline recommendations in general practice: awareness, agreement, adoption, and adherence.

Authors:  Carl Heneghan; Rafael Perera; David Mant; Paul Glasziou
Journal:  Br J Gen Pract       Date:  2007-12       Impact factor: 5.386

8.  Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study.

Authors:  Brian Serumaga; Dennis Ross-Degnan; Anthony J Avery; Rachel A Elliott; Sumit R Majumdar; Fang Zhang; Stephen B Soumerai
Journal:  BMJ       Date:  2011-01-25

9.  Undiagnosed hypertension among young adults with regular primary care use.

Authors:  Heather M Johnson; Carolyn T Thorpe; Christie M Bartels; Jessica R Schumacher; Mari Palta; Nancy Pandhi; Ann M Sheehy; Maureen A Smith
Journal:  J Hypertens       Date:  2014-01       Impact factor: 4.844

10.  Surveillance of ischemic heart disease should include physician billing claims: population-based evidence from administrative health data across seven Canadian provinces.

Authors:  Cynthia Robitaille; Christina Bancej; Sulan Dai; Karen Tu; Drona Rasali; Claudia Blais; Céline Plante; Mark Smith; Lawrence W Svenson; Kim Reimer; Jill Casey; Rolf Puchtinger; Helen Johansen; Yana Gurevich; Chris Waters; Lisa M Lix; Hude Quan
Journal:  BMC Cardiovasc Disord       Date:  2013-10-20       Impact factor: 2.298

View more
  13 in total

1.  The effect of hormone replacement therapy on the survival of UK women: a retrospective cohort study 1984-2017.

Authors:  N Akter; E Kulinskaya; N Steel; I Bakbergenuly
Journal:  BJOG       Date:  2021-11-25       Impact factor: 7.331

2.  Genetic and phenotypic profiling of supranormal ejection fraction reveals decreased survival and underdiagnosed heart failure.

Authors:  Iain S Forrest; Ghislain Rocheleau; Shantanu Bafna; Edgar Argulian; Jagat Narula; Pradeep Natarajan; Ron Do
Journal:  Eur J Heart Fail       Date:  2022-03-12       Impact factor: 17.349

3.  Observational study protocol for evaluating control of hypertension and the effects of social determinants.

Authors:  Heather Angier; Nathalie Huguet; Miguel Marino; Beverly Green; Heather Holderness; Rachel Gold; Megan Hoopes; Jennifer DeVoe
Journal:  BMJ Open       Date:  2019-03-15       Impact factor: 2.692

4.  Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study.

Authors:  Emily Herrett; Sarah Gadd; Rod Jackson; Krishnan Bhaskaran; Elizabeth Williamson; Tjeerd van Staa; Reecha Sofat; Adam Timmis; Liam Smeeth
Journal:  Lancet       Date:  2019-07-25       Impact factor: 202.731

5.  Combining population-based administrative health records and electronic medical records for disease surveillance.

Authors:  Saeed Al-Azazi; Alexander Singer; Rasheda Rabbani; Lisa M Lix
Journal:  BMC Med Inform Decis Mak       Date:  2019-07-02       Impact factor: 2.796

6.  Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries.

Authors:  Edith M Heintjes; Irene D Bezemer; Daniel Prieto-Alhambra; Elisabeth Smits; Helen P Booth; Daniel Dedman; Ying He; Fabian Hoti; Minna Vehkala; Stefan de Vogel; Noah Jamie Robinson; Kwame Appenteng; Fernie J A Penning-van Beest
Journal:  Clin Epidemiol       Date:  2020-05-01       Impact factor: 4.790

7.  Assessing HIV Care Outcomes Among African-Born People Living with HIV in Seattle: An Analysis of the University of Washington Electronic Medical Record.

Authors:  Steven Erly; D Allen Roberts; Roxanne Kerani; H Nina Kim; Robert Harrington; Shireesha Dhanireddy; Rena Patel
Journal:  J Immigr Minor Health       Date:  2020-11-18

8.  Blood pressure at age 60-65 versus age 70-75 and vascular dementia: a population based observational study.

Authors:  Mingkai Peng; Guanmin Chen; Karen L Tang; Hude Quan; Eric E Smith; Peter Faris; Vladimir Hachinski; Norm R C Campbell
Journal:  BMC Geriatr       Date:  2017-10-27       Impact factor: 3.921

9.  Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis.

Authors:  John R Hurst; Maria Dilleen; Kevin Morris; Siân Hills; Birol Emir; Rupert Jones
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-03-05

10.  Hypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research.

Authors:  Paulette D Chandler; Cheryl R Clark; Guohai Zhou; Nyia L Noel; Confidence Achilike; Lizette Mendez; Andrea H Ramirez; Roxana Loperena-Cortes; Kelsey Mayo; Elizabeth Cohn; Lucila Ohno-Machado; Eric Boerwinkle; Mine Cicek; Jun Qian; Sheri Schully; Francis Ratsimbazafy; Stephen Mockrin; Kelly Gebo; Julien J Dedier; Shawn N Murphy; Jordan W Smoller; Elizabeth W Karlson
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.